Increase of bone mineral density and anabolic variables in patients with rheumatoid arthritis resistant to methotrexate after cyclosporin A therapy

Journal of Rheumatology

Volumn 23, Issue 9, 1996, Pages 1539-1542

  Ferraccioli, Gianfranco ^a   Casatta, Lucia ^a   Bartoli, Ettore ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

Bone density; Cyclosporin A; Methotrexate

Indexed keywords

CYCLOSPORIN A; METHOTREXATE; OSTEOCALCIN; PRASTERONE SULFATE; PREDNISONE; SOMATOMEDIN C;

ADULT; ARTICLE; BONE DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ACUTE-PHASE PROTEINS; ARTHRITIS, RHEUMATOID; BONE DENSITY; C-REACTIVE PROTEIN; CYCLOSPORINE; DEHYDROEPIANDROSTERONE SULFATE; DRUG RESISTANCE; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; JOINTS; MALE; METHOTREXATE; MIDDLE AGED; OSTEOCALCIN; RETREATMENT;

EID: 0029742877     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Gough AKS, Lilley J, Eyre S, Holder RL, Emery P: Generalized bone loss in patients with early rheumatoid arthritis. Lancet 1994;344:23-7.
2. Michel BA, Bloch DA, Fries JF: Predictors of fractures in early rheumatoid arthritis. J Rheumatol 1991;18:804-8.
3. Bensen W, Tugwell P, Roberts RM, et al: Combination therapy of cyclosporin with methotrexate and gold in rheumatoid arthritis (2 pilot studies). J Rheumatol 1994;21:2034-8.
4. Arnett FC, Edworthy SM, Bloch DA, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:1054-60.
5. Felson DT, Anderson JJ, Boers M, et al: The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36:729-40.
6. Fries JF, Spitz PW, Young DY: The dimension of health outcomes: the Health Assessment Questionnaire. J Rheumatol 1982;9:789-93.
7. Ferraccioli GF, Salaffi F, Troise-Rioda W, Bartoli E: The chronic arthritis systemic index (CASI). Clin Exp Rheumatol 1994;12:241-8.
8. Ferraccioli GF, Guerra P, Rizzi V, Bartoli E: Cyclosporin A increases somatomedin C (IGF-1) levels in chronic rheumatic diseases. J Rheumatol 1995;22:1060-4.
9. An international consensus report: The use of Cyclosporin A in rheumatoid arthritis. Br J Rheumatol 1993;(suppl 1)32:1-3.
10. Tugwell P, Pincus T, Yocum D, et al: Combination therapy with cyclosporin and methotrexate in severe rheumatoid arthritis. N Engl J Med 1995;333:137-41.
11. Cvetkovic M, Mann GN, Romero DF, Liang X, Jee WSS, Epstein S: The deleterious effects of long term cyclosporin A, cyclosporin G and FK 506 on bone mineral metabolism. Transplantation 1994;57:1231-7.
12. Epstein S, Shane E, Bilezikian JP: Organ transplantation and osteoporosis. Curr Opinion Rheumatol 1995;7:255-61.
13. May KP, West SG, McDermott MT, Huffer WE: The effect of low-dose MTX on bone metabolism and histomorphometry in rats. Arthritis Rheum 1994;37:201-6.
14. Sambrook PN, Kelly PJ, Fontana D, et al: Mechanism of rapid bone loss following cardiac transplantation. Osteoporosis Int 1994;4:273-6.
15. Julian BA, Laskow DA, Dubosky J, Curtis JJ, Quarles LD: Rapid loss of vertebral bone density after renal transplantation. N Engl J Med 1991;325:544-50.
16. Gnudi S, Butturini L, Ripamonti C, Avella M, Bacci G: The effects of methotrexate on bone. Ital J Orthop Traumatol 1988;14:227-31.
17. Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM: Effects of low dose corticosteroids on bone mineral density of patients with rheumatoid arthritis. J Rheumatol 1995;22:1055-9.
18. Pasero G, Priolo E, Marubini E, et al: Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A. Arthritis Rheum 1996;39:1006-15.
19. Pasero G. on behalf of GRISAR: Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A. Results after 24 months (abstr). Arthritis Rheum 1995;(suppl 9)38:777.
20. Laan RFJM, van Riel PLCM, van de Putte LBA, et al: Low dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. Ann Intern Med 1993;119:963-8.
21. Okazaki R, Riggs BL, Conover CA: Glucocorticoid regulation of insulin-like growth factor binding protein expression in normal human osteoblast-like cells. Endocrinology 1994;134:126-32.
22. del Pozo E, Zapf J: Skeletal growth and bone density as sensitive parameters in experimental arthritis. Effect of cyclosporin A. Bone 1994;15:625-8.